Investor Overview
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.72
May. 08, 2024 16:00:00- Change -0.17 (-5.8824%)
- Volume 30,987
- Today's Open 2.86
- Previous Close 2.89
- Today's High 2.92
- Today's Low 2.6601
- 52 Week High 7.88
- 52 Week Low 1.67